Pervasive Developmental Disorder NOS Unknown Status Phase 1 / 2 Trials for Naltrexone (DB00704)

Also known as: Pervasive Developmental Disorder / Pervasive Developmental Disorders / Autistic continuum / Pervasive Development Disorders / Atypical autism / Autism spectrum disorder

IndicationStatusPhase
DBCOND0046531 (Pervasive Developmental Disorder NOS)Unknown Status1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00318162Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)Treatment